Wednesday, April 7, 2010 as of 11:14 AM ET
Biotechnology (sometimes shortened to "biotech") is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts.
Read More at Wikipedia ›Genetic Technologies Ltd.
shares soared 51% to $5.36 on Thursday. Shares of the Australian biotech group have been on a roll since Tuesday, when the company released a positive business update for its BREVAGen genetic test for breast cancer. The product is used to test for certain genetic variations that are associated with an increased risk of developing the disease. Shares of Genetic Technologies are up 123% for the week and 73% since the beginning of the year.Copyright © 2012 MarketWatch, Inc....Shares of Dendreon Corp. slid 8% to $7.91 on Thursday following news that the Securities and Exchange Commission has launched a formal investigation into the biotech...
Human Genome Sciences (NASDSAQ:HGSI) has adopted a stockholder rights plan - known widely as a "poison pill" defense strategy - in an effort to protect itself from a...
Human Genome Sciences Inc. (HGSI) adopted a shareholder rights plan with a 15% trigger in the wake of GlaxoSmithKline PLC's (GSK, GSK.LN) $2.6 billion hostile takeov...
Shares of Amylin Pharmaceuticals climbed 6% in early trading Tuesday after analysts at Leerink Swann said they see Sanofi and Merck emerging as the strongest bidders...
Here are stocks that gapped down today with opening prices significantly lower than the previous trading day's close:GSV Capital (NASDAQ:GSVC) opened at $16.27 after...
Mark Tepper, Strategic Wealth Partners president, on quantitative easing and its impact on the market, and how investors can make defensive choices.
Which stock index should you follow?Whether it's the Dow Jones industrial average, the Nasdaq stock market, Standard & Poor's 500 index or the Russell 2000, investor...
Shares of Dynavax Technologies tumbled 24% to $3.88 on Wednesday after the biotech group priced a stock offering at a 17% discount to Tuesday's closing price. Dynava...
Weeks after being publicly rebuffed, British drug maker GlaxoSmithKline (NYSE:GSK) unveiled a $2.6 billion hostile takeover bid for biotechnology company Human Genom...
GlaxoSmithKline PLC (GSK) said Wednesday it's taking its hostile $2.6 billion takeover offer for Human Genome Sciences Inc (HGSI) direct to the U.S. biotech's shareh...
Shares of Dendreon Corp. tumbled 22% to $9.08 on Tuesday, the day after the biotech firm issued a weaker-than-expected earnings report. Analysts at Leerink Swann on ...
Dow Chemical Co.'s (DOW) agribusiness arm is actively on the hunt for acquisitions as it seeks to grow its share of the market for seeds in key grain-producing regio...
Shares of Genetic Technologies Ltd. rallied 45% to $3.49 after the Australian biotech company issued a positive business update for its BREVAGen genetic test for bre...
Shares of Achillion Pharmaceuticals jumped 11% to $7.24 on Monday after the biotech group released a positive Phase I study on its hepatitis C drug candidate ACH-268...
Shares of Osiris Therapeutics continued to rally Monday on last week's news that the biotech group had won approval in Canada for its stem-cell therapy Prochymal. Os...
And you thought Silicon Valley was exclusive?Meet Blueseed, which, after it sets out to sea in 2013, will be the first-ever sea-based tech incubator, according to it...
Investors have drained almost $26 billion in market capitalization from J.P. Morgan Chase & Co. (JPM) since the bank announced a surprise $2 billion trading loss a w...
Strategic Wealth Partners V.P. Tony Zabiegala on the economy’s bearish outlook.
Strategic Wealth Partners V.P. Tony Zabiegala on why investors should consider biotech for their portfolios.
